Categories AlphaGraphs, Earnings, Health Care

Vertex Pharmaceuticals (VRTX) Earnings: 4Q22 Key Numbers

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) reported total revenues of $2.3 billion for the fourth quarter of 2022. This compares to $2 billion in the same period a year ago.

GAAP net income rose 6% year-over-year to $819 million, or $3.15 per share. Adjusted EPS increased 25% to $3.76.

For full-year 2023, CF product revenues are expected to be $9.55-9.70 billion.

Looking for more insights on the earnings results? Click here to access the full transcripts of the latest earnings conference calls!

Most Popular

Infographic: How Macy’s (M) performed in Q4 2023 financial results

Macy’s, Inc. (NYSE: M) reported fourth quarter 2023 earnings results today. Net sales were $8.1 billion, down 1.7% versus the same period a year ago. Total revenue dropped to $8.37

AZO Earnings: AutoZone’s Q2 2024 earnings rise on higher sales

AutoZone, Inc. (NYSE: AZO) announced financial results for the second quarter of 2024, reporting higher sales and net profit. The company had a total of 7,191 stores open at the end

SJM Earnings: Key quarterly highlights from J.M. Smucker’s Q3 2024 financial results

The J.M. Smucker Co. (NYSE: SJM) reported third quarter 2024 earnings results today. Net sales increased 1% year-over-year to $2.23 billion. Comparable sales increased 6%. Net income decreased 42% to

Add Comment
Viewing Highlight